BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 9504514)

  • 1. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
    Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
    Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.
    Stevens RF; Hann IM; Wheatley K; Gray RG
    Br J Haematol; 1998 Apr; 101(1):130-40. PubMed ID: 9576193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.
    Woods WG; Neudorf S; Gold S; Sanders J; Buckley JD; Barnard DR; Dusenbery K; DeSwarte J; Arthur DC; Lange BJ; Kobrinsky NL;
    Blood; 2001 Jan; 97(1):56-62. PubMed ID: 11133742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
    Kimby E; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
    Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
    N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission.
    Tiedemann K; Waters KD; Tauro GP; Tucker D; Ekert H
    Blood; 1993 Dec; 82(12):3730-8. PubMed ID: 8260710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.
    Gibson BE; Wheatley K; Hann IM; Stevens RF; Webb D; Hills RK; De Graaf SS; Harrison CJ
    Leukemia; 2005 Dec; 19(12):2130-8. PubMed ID: 16304572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.
    Sierra J; Brunet S; Grañena A; Olivé T; Bueno J; Ribera JM; Petit J; Besses C; Llorente A; Guardia R; Macía J; Rovira M; Badell I; Vela E; Díaz de Heredia C; Vivancos P; Carreras E; Feliu E; Montserrat E; Julía A; Cubells J; Rozman C; Domingo A; Ortega JJ
    J Clin Oncol; 1996 Apr; 14(4):1353-63. PubMed ID: 8648394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
    Chessells JM; Bailey C; Wheeler K; Richards SM
    Lancet; 1992 Sep; 340(8819):565-8. PubMed ID: 1355153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.
    Webb DK; Wheatley K; Harrison G; Stevens RF; Hann IM
    Leukemia; 1999 Jan; 13(1):25-31. PubMed ID: 10049056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.
    Thomas X; Le Q; Botton Sd; Raffoux E; Chelghoum Y; Pautas C; Dreyfus F; Dhedin N; Vekhoff A; Troncy J; Pigneux A; Revel Td; Reman O; Travade P; Thiebaut A; Guerci A; Elhamri M; Fenaux P; Dombret H; Michallet M
    Leuk Lymphoma; 2005 Jul; 46(7):1007-16. PubMed ID: 16019551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
    Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
    Borgmann A; Schmid H; Hartmann R; Baumgarten E; Hermann K; Klingebiel T; Ebell W; Zintl F; Gadner H; Henze G
    Lancet; 1995 Sep; 346(8979):873-6. PubMed ID: 7564672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AML.
    Harousseau JL; Pignon B; Dufour P; Ifrah N; Solary E; Abgrall JF; Milpied N; Desablens B; Guyotat D; Herve P
    Leukemia; 1992; 6 Suppl 2():120-3. PubMed ID: 1578912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
    Harousseau JL; Cahn JY; Pignon B; Witz F; Milpied N; Delain M; Lioure B; Lamy T; Desablens B; Guilhot F; Caillot D; Abgrall JF; Francois S; Briere J; Guyotat D; Casassus P; Audhuy B; Tellier Z; Hurteloup P; Herve P
    Blood; 1997 Oct; 90(8):2978-86. PubMed ID: 9376578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.
    Shaw PJ; Bergin ME; Burgess MA; Dalla Pozza L; Kellie SJ; Rowell G; Stevens MM; Webster BH; Bradstock KF
    J Clin Oncol; 1994 Oct; 12(10):2138-45. PubMed ID: 7931485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.